$QLYS

Hank Jeffrey P sold $103K of QLYS

Hank Jeffrey P sold 940 shares of QUALYS, INC. (QLYS) at an average of $109.82 ($108.88–$110.75, $0.10M total) across 2 trades over 2026-06-11 to 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hank Jeffrey P
Published Jun 15, 2026, 8:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QLYS
Neutral
high confidence
Mentioned
$QLYS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QLYSNeutralLow
01

Why it matters

The newest information is the specific sale size, dates, and price range under a pre-arranged 10b5-1 plan; it can marginally influence sentiment but does not provide new business or financial guidance.

02

Market read

Insider selling disclosure may cause minor, short-term sentiment noise, but lacks fundamental catalysts in the text.

03

What to watch

Traders may look for clustering of insider sales across multiple directors/officers or unusually large sales versus typical patterns—none is established here beyond this single disclosure.

Relevance 3/10Novelty 6/10Timing: Filed 2026-06-15 (SEC Form 4) for sales dated 2026-06-11 to 2026-06-12

Background

The article is an SEC Form 4 insider transaction disclosure for Qualys, Inc. (director role).

Company-level read

Ticker impact

$QLYSNeutralHigh confidence
Context

Qualys director Hank Jeffrey P filed an open-market sale of 940 shares under a pre-arranged 10b5-1 plan at ~$108.88–$110.75.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless accompanied by other new company news.

Evidence & confidence

The filing is a Form 4 insider transaction (10b5-1 pre-arranged) with modest share count and no accompanying guidance, deal, or regulatory development in the text.

Market effects

No sector-level read-through; this is company-specific insider liquidity/portfolio management.

None indicated.

None indicated.

Counterpoint

10b5-1 plans are often used to reduce timing risk; selling can be unrelated to outlook and may not signal bearish fundamentals.

Key entities

  • QUALYS, INC.

    Subject of the Form 4 insider transaction; director Hank Jeffrey P sold shares under a 10b5-1 plan.

  • Hank Jeffrey P

    Director who executed an open-market sale of 940 shares across two trades.

Related articles

$QLYSMedAI 8/10

Qualys, Inc. Q2 2026 Earnings Call Summary

Qualys reported Q2 2026 earnings call updates focused on AI-driven threat acceleration and shifting bottlenecks from detection to remediation. Management raised full-year 2026 revenue guidance to $732 million–$738 million, assuming ~105% net dollar expansion. It cited 22% channel-led growth, 54% of revenue from partners, and $76.8 million in Q2 buybacks. Qualys also highlighted FedRAMP High and CISA 72-hour remediation mandates.

$QLYSHighAI 9/10

Why Qualys Stock Crushed it on Wednesday

Qualys (NASDAQ: QLYS) reported Q2 results before market open, posting revenue of about $182.2M, up 11% year over year, and non-GAAP net income above $69M, up 13% to $1.98 per share. The company cited sustained demand and AI-enhanced offerings. Guidance for Q3 and FY2026 included revenue and adjusted EPS targets that beat consensus, and shares rose nearly 14% on the day.